Literature DB >> 2511320

Radiometric studies on the use of selective inhibitors in the identification of Mycobacterium spp.

T Collins1, P N Levett.   

Abstract

Radiometric selective inhibition tests were developed and evaluated for the rapid differentiation of Mycobacterium spp. Both a p-nitrobenzoic acid (PNB) test and a commercially-prepared p-nitro-alpha-acetylamino-beta-hydroxypropiophenone (NAP) test successfully differentiated M. tuberculosis and M. bovis from "atypical" mycobacteria or mycobacteria other than tubercle bacilli (MOTT). Thiophene-2-carboxylic acid hydrazide (TCH) readily distinguished human M. tuberculosis strains from M. bovis, irrespective of resistance to isoniazid. Both PNB and TCH tests were utilised in a routine radiometric susceptibility testing scheme over a period of 1 year in which 110 isolates of M. tuberculosis, 10 of M. bovis and one isolate of BCG were correctly differentiated from 10 isolates of MOTT. The rapidity, sensitivity and specificity of these radiometric tests can play a useful role in mycobacterial identification.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511320     DOI: 10.1099/00222615-30-3-175

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  Evaluation of the BACTEC MGIT 960 and MB BAC/T systems for routine detection of Mycobacterium tuberculosis.

Authors:  T Whyte; B Hanahoe; T Collins; G Corbett-Feeney; M Cormican
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Evaluation of a PCR based method for identification of mycobacterial isolates.

Authors:  M G Cormican; M Glennon; U Ni Riain; J Flynn
Journal:  Ir J Med Sci       Date:  1995-01       Impact factor: 1.568

3.  Modification of results of drug susceptibility tests by coexistence of Mycobacterium avium complex with Mycobacterium tuberculosis in a sputum sample: case report and experimental considerations.

Authors:  K Suzuki; T Kimoto; K Tsuyuguchi; H Matsumoto; A Niimi; E Tanaka; T Murayama; R Amitani
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Molecular epidemiological studies of Mycobacterium bovis infections in humans and animals in Sweden.

Authors:  R Szewzyk; S B Svenson; S E Hoffner; G Bölske; H Wahlström; L Englund; A Engvall; G Källenius
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

5.  Tuberculosis in the west of Ireland 1986-1990.

Authors:  M G Cormican; J Flynn
Journal:  Ir J Med Sci       Date:  1992-03       Impact factor: 1.568

6.  Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis.

Authors:  Linda M Parsons; Roland Brosch; Stewart T Cole; Akos Somoskövi; Arthur Loder; Gisela Bretzel; Dick Van Soolingen; Yvonne M Hale; Max Salfinger
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

7.  Biochemical heterogeneity of Mycobacterium tuberculosis complex isolates in Guinea-Bissau.

Authors:  S E Hoffner; S B Svenson; R Norberg; F Dias; S Ghebremichael; G Källenius
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

8.  Evaluation of a Rapid Differentiation Test for Mycobacterium Tuberculosis from other Mycobacteria by Selective Inhibition with p-nitrobenzoic Acid using MGIT 960.

Authors:  Babita Sharma; Nita Pal; Bharti Malhotra; Leela Vyas
Journal:  J Lab Physicians       Date:  2010-07

9.  Pulmonary tuberculosis caused by Mycobacterium bovis in China.

Authors:  Guanglu Jiang; Guirong Wang; Suting Chen; Xia Yu; Xiaobo Wang; Liping Zhao; Yifeng Ma; Lingling Dong; Hairong Huang
Journal:  Sci Rep       Date:  2015-03-04       Impact factor: 4.379

10.  The Diversity Outbred Mouse Population Is an Improved Animal Model of Vaccination against Tuberculosis That Reflects Heterogeneity of Protection.

Authors:  Sherry L Kurtz; Amy P Rossi; Gillian L Beamer; Dan M Gatti; Igor Kramnik; Karen L Elkins
Journal:  mSphere       Date:  2020-04-15       Impact factor: 4.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.